Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.8K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.8K
Ecological Succession02:17

Ecological Succession

21.5K
Ecological succession is influenced by the processes of facilitation, inhibition, and toleration. Facilitation occurs when early successional species create more favorable ecological conditions for subsequent species, such as enhanced nutrient, water, or light availability. In contrast, inhibition happens when early successional species create unfavorable ecological conditions for potential successive species, such as limiting resource availability. In some cases, later successional species...
21.5K
Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

532
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
532
Pharmaceutical Equivalents01:26

Pharmaceutical Equivalents

201
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
201
Accelerators01:17

Accelerators

288
Accelerators in concrete serve as admixtures to speed up the hardening process, enabling the concrete to achieve early strength faster. Although accelerators do not necessarily impact the time it takes concrete to set, they reduce this time in practice. A common accelerator is calcium chloride, which is particularly useful for hastening early strength development in cold weather or for rapid repair jobs that require quick heat generation after mixing.
The effectiveness of calcium chloride can...
288
Group Design02:01

Group Design

10.5K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
10.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanistic insights into a heterobifunctional degrader-induced PTPN2/N1 complex.

Communications chemistry·2024
Same author

Cryo-EM structure of human PAPP-A2 and mechanism of substrate recognition.

Communications chemistry·2023
Same author

Identification and structure-based drug design of cell-active inhibitors of interleukin 17A at a novel C-terminal site.

Scientific reports·2022
Same author

Sugar phosphate activation of the stress sensor eIF2B.

Nature communications·2021
Same author

<i>Polo</i>: an open-source graphical user interface for crystallization screening.

Journal of applied crystallography·2021
Same author

Development of Orally Efficacious Allosteric Inhibitors of TNFα via Fragment-Based Drug Design.

Journal of medicinal chemistry·2020

Related Experiment Video

Updated: Feb 2, 2026

Structural Design and Manufacturing of a Cruiser Class Solar Vehicle
14:57

Structural Design and Manufacturing of a Cruiser Class Solar Vehicle

Published on: January 30, 2019

14.4K

Accelerating pharmaceutical structure-guided drug design: a successful model.

Lisa J Keefe1, Vincent S Stoll2

  • 1Hauptman-Woodward Medical Research Institute, Buffalo, NY 14203 USA; Industrial Macromolecular Crystallography Association - Collaborative Access Team (IMCA-CAT), Advanced Photon Source, Argonne National Laboratory, 9700 S. Cass Avenue, Argonne, IL, 60439 USA.

Drug Discovery Today
|November 19, 2018
PubMed
Summary

Structure-based drug design drives pharmaceutical discovery. The Industrial Macromolecular Crystallography Association-Collaborative Access Team (IMCA-CAT) facility offers comprehensive resources for industrial structural research, ensuring high-quality data and accessibility.

More Related Videos

Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols
15:04

Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols

Published on: May 20, 2016

11.4K
Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
07:00

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface

Published on: August 11, 2017

8.7K

Related Experiment Videos

Last Updated: Feb 2, 2026

Structural Design and Manufacturing of a Cruiser Class Solar Vehicle
14:57

Structural Design and Manufacturing of a Cruiser Class Solar Vehicle

Published on: January 30, 2019

14.4K
Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols
15:04

Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols

Published on: May 20, 2016

11.4K
Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
07:00

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface

Published on: August 11, 2017

8.7K

Area of Science:

  • Biophysics and structural biology
  • Drug discovery and development
  • Industrial research infrastructure

Background:

  • Structure-based drug design is crucial for modern pharmaceutical discovery, yielding numerous successful therapies.
  • The Industrial Macromolecular Crystallography Association-Collaborative Access Team (IMCA-CAT) has supported this field for over 25 years.
  • IMCA-CAT operates as a premier research facility at Argonne National Laboratory's synchrotron.

Purpose of the Study:

  • To highlight the unique, industry-focused capabilities of the IMCA-CAT facility.
  • To provide guidance for industrial organizations seeking access to IMCA-CAT.
  • To underscore the value of integrated structural research resources for drug development.

Main Methods:

  • Comprehensive facility design catering to evolving industrial needs.
  • Provision of year-round high-quality data collection.
  • Ensuring adaptable capabilities, high throughput, and robust security.

Main Results:

  • IMCA-CAT offers a unique, consolidated resource for industrial structural research.
  • The facility meets diverse industry demands with scalable capacity and consistent data quality.
  • Established protocols facilitate broad access for industrial organizations.

Conclusions:

  • IMCA-CAT provides essential, integrated infrastructure for advancing structure-based drug design.
  • The facility's model ensures that throughput and capacity are not limiting factors for industry.
  • Industrial organizations can leverage IMCA-CAT's unique capabilities to accelerate drug discovery pipelines.